TIP
GSK icon

Torray Investment Partners’s GSK GSK Stock Holding History

Torray Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,200
Closed -$250K – 112
2016
Q4 		$250K Sell
5,200
-1,000
-16% -$49.4K 0.03% 109
2016
Q3 		$334K Hold
6,200
– – 0.04% 79
2016
Q2 		$336K Buy
+6,200
New +$327K 0.03% 78
2014
Q4 		– Sell
-6,200
Closed -$356K – 72
2014
Q3 		$356K Hold
6,200
– – 0.03% 71
2014
Q2 		$414K Buy
+6,200
New +$420K 0.04% 66

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Torray Investment Partners's GSK Position: Q1 2017 in Review

Torray Investment Partners sold out of GSK (GSK) in Q1 2017, closing a stake of 5,200 shares — an estimated $250K sold.

Torray Investment Partners first reported a position in GSK in Q2 2014 and held it in 5 quarters. The position peaked at $414K in Q2 2014. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

  • Torray Investment Partners reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
  • Torray Investment Partners sold 5,200 GSK shares in Q1 2017, an estimated $250K.
  • Torray Investment Partners first reported a position in GSK in Q2 2014 and held it in 5 quarters.
  • Torray Investment Partners's GSK position peaked at $414K in Q2 2014.
  • 786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Torray Investment Partners's 13F filing for Q1 2017, filed 12 May 2017.